- By insider
President and CEO of Kura Oncology Inc (30-Year Financial, Insider Trades) Troy Edward Wilson (insider trades) sold 116,901 shares of KURA on 09/14/2020 at an average price of $28.69 a share. The total sale was $3.4 million.
Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. Kura Oncology Inc has a market cap of $1.59 billion; its shares were traded at around $28.33 . GuruFocus has detected 1 severe warning sign with Kura Oncology Inc. .
CEO Recent Trades:
-
President and CEO Troy Edward Wilson sold 116,901 shares of KURA stock on 09/14/2020 at the average price of $28.69. The price of the stock has decreased by 1.25% since.
-
President and CEO Troy Edward Wilson sold 88,055 shares of KURA stock on 09/10/2020 at the average price of $26.86. The price of the stock has increased by 5.47% since.
-
President and CEO Troy Edward Wilson sold 29,621 shares of KURA stock on 08/25/2020 at the average price of $22.3. The price of the stock has increased by 27.04% since.
-
President and CEO Troy Edward Wilson sold 75,335 shares of KURA stock on 08/19/2020 at the average price of $22.02. The price of the stock has increased by 28.66% since.
CFO Recent Trades:
-
CFO, CBO Marc Grasso sold 10,000 shares of KURA stock on 09/14/2020 at the average price of $29. The price of the stock has decreased by 2.31% since.
-
CFO, CBO Marc Grasso sold 10,000 shares of KURA stock on 09/08/2020 at the average price of $26. The price of the stock has increased by 8.96% since.
-
CFO, CBO Marc Grasso sold 10,000 shares of KURA stock on 08/25/2020 at the average price of $23. The price of the stock has increased by 23.17% since.
Directors and Officers Recent Trades:
-
COO Kathleen Ford sold 12,500 shares of KURA stock on 09/15/2020 at the average price of $29.43. The price of the stock has decreased by 3.74% since.
For the complete insider trading history of KURA, click here
.This article first appeared on GuruFocus.